Primary Paraganglioma of the Thyroid Gland: Clinical and Immunohistological Analysis with a Literature Review - European Medical Journal

Primary Paraganglioma of the Thyroid Gland: Clinical and Immunohistological Analysis with a Literature Review

Oncology
Download PDF
Authors:
*Julien Feghaly,1 George Astras,2 Marios Loizou,3 Giannis Panayiotou,3 Ariana Mooradian1
Disclosure:

The authors have declared no conflicts of interest.

Received:
14.12.15
Accepted:
23.02.16
Citation:
EMJ. ;1[2]:101-106. DOI/10.33590/emj/10314311. https://doi.org/10.33590/emj/10314311.
Keywords:
Primary paraganglioma, thyroid gland, clinical immunohistological analysis, medullary carcinoma, hyalinising adenoma

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Primary paraganglioma of the thyroid is a rare neuroendocrine tumour, often mistaken for other thyroid neoplasms. Here, we describe a case of initially misdiagnosed primary paraganglioma of the thyroid and study its clinical presentation, management, investigation, and immunohistological findings.

A 72-year-old male presented with a left-sided solitary thyroid lobe and isthmus nodule. Ultrasound, fine needle aspiration, and computed tomography did not provide a clear diagnosis and subsequently, a left lobectomy and isthmusectomy were performed. The initial histopathological findings of the tumour revealed positivity to chromogranin and calcitonin, suggesting a medullary carcinoma replacing the left lobe of the thyroid. In a second histopathological review at an external laboratory, the tumour cells showed positive focal staining for chromogranin, but were negative for both calcitonin and monoclonal carcinoembryonic antigen, suggesting thyroid paraganglioma. This case highlights the importance of accurate histopathological diagnosis and the need to be aware of the possibility of thyroid paraganglioma initially presenting as a thyroid nodule.

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?